Skip to content

Insider · CIK 0001493698

Michael J. Hamilton

director

Files at CODA (Coda Octopus Group, Inc.). First filing -, latest -.

Michael J. Hamilton files SEC Form 4 as director at CODA (Coda Octopus Group, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Michael J. Hamilton has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 28, 2026CODA
Coda Octopus Group, Inc.
AGrant or award
Common Stock
+1,102$0.00$06,635Jun 24, 2026
Mar 16, 2025CODA
Coda Octopus Group, Inc.
AGrant or award
Common Stock
+2,266$0.00$07,799Mar 18, 2025

Questions about Michael J. Hamilton

Answered from the filings on this page, as of the latest one.

Is Michael J. Hamilton buying or selling?

Michael J. Hamilton has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Michael J. Hamilton's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael J. Hamilton has 0.

Where does Michael J. Hamilton file Form 4?

Michael J. Hamilton has filed Form 4 at CODA (Coda Octopus Group, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.